SamSearch

    Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES

    FDA LICENSED EBOLA VIRUS THERAPEUTICS

    Issued by ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE · BARDA - ASPR / DAAPPO / BARDA DCMA
    Sol. BARDA-CBRN-022026Sources SoughtWASHINGTON, DC
    Closed
    STATUS
    Closed
    closed Mar 13, 2026
    POSTED
    Feb 20, 2026
    Publication date
    NAICS CODE
    541715
    Primary industry classification
    PSC CODE
    6505
    Product & service classification

    AI Summary

    The Biomedical Advanced Research and Development Authority (BARDA) is seeking feedback from biopharmaceutical partners regarding FDA licensed Ebola virus therapeutics. This Sources Sought Notice aims to gather information for future acquisitions and programs, emphasizing the importance of collaboration in healthcare advancements.

    Contract details

    Solicitation No.
    BARDA-CBRN-022026
    Notice Type
    Sources Sought
    Posted Date
    February 20, 2026
    Response Deadline
    March 13, 2026
    NAICS Code
    541715AI guide
    PSC / Class Code
    6505
    Issuing Office
    BARDA - ASPR / DAAPPO / BARDA DCMA
    Sub-Agency
    ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
    Agency
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Primary Contact
    Yifan Yang
    City
    WASHINGTON
    State
    DC
    ZIP Code
    20515
    AI Product/Service
    both

    Description

    The Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR) at the United States (U.S.) Department of Health and Human Services (HHS), is issuing this SSN to collect feedback from current and potential biopharmaceutical partners. Information collected from this SSN will serve as continued market research for possible future acquisitions and programs.

    Key dates

    1. February 20, 2026Posted Date
    2. March 13, 2026Proposals / Responses Due

    AI search tags

    biopharmaceuticalshealthcare servicestherapeuticsebola virusgovernment contracting

    Frequently asked questions

    FDA LICENSED EBOLA VIRUS THERAPEUTICS is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.

    Book a Demo